|
Clinical Applications |
This product is suitable for the following infections caused by sensitive
pathogenic strains:
1.The community acquired pneumonia which intravenous treatment is needed at
first caused by Chlamydia pneumoniae, Haemophilus influenzae bacteria,
Legionella pneumophila, catarrhal mora bacteria, Mycoplasma pneumoniae,
Staphylococcus aureus or Streptococcus pneumoniae .
(2) Pelvic inflammatory disease which intravenous treatment is needed at first
caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma hominis. |
